(Press-News.org) JUPITER, FL, October 3, 2013 – Scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified a new drug candidate for an inherited form of cancer with no known cure.
The new study showed the drug candidate—known as FRAX97—slowed the proliferation and progression of tumor cells in animal models of Neurofibromatosis type 2. This inherited type of cancer, caused by mutations in the anti-tumor gene NF2, leads to tumors of the auditory nerve that connects the inner ear to the brain.
The new compound, originally developed to treat neurodegenerative disease, targets a protein family known as p21-activated kinases or PAKs. These kinases (enzymes that add a phosphate group to other proteins and change their function) play a critical role in the development of Neurofibromatosis type 2. PAK1 has also been implicated in the growth of breast and lung cancers.
"Our study shows that if we inhibit these kinases we can counter the formation of tumors in this brain disease," said Joseph Kissil, a TSRI associate professor who led the study.
In the new study, published in the October 4, 2013 issue of The Journal of Biological Chemistry, Kissil and his colleagues showed that the inhibitor slows down progression of Neurofibromatosis type 2 in animal models and reduces more than 80 percent of PAK1 activity.
Kissil notes a key challenge in developing drug candidates is finding potential agents that are both potent and highly selective for their targets—limiting its action to the desired arena and reducing unwanted side effects.
"This inhibitor turned out to be both potent and highly selective," he said. "The real question is why. We were able to show that it works through a unique mechanism."
While the binding site on PAK1 is quite large, it also contains a smaller pocket, a kind of backroom that juts off the larger site. The inhibitor not only takes up space in the larger site, but enters the back pocket as well. That extra binding gives the inhibitor its strong selectivity.
INFORMATION:
The first authors of the study, "FRAX597, a Small Molecule Inhibitor of The P21-Activated Kinases, Inhibits Tumorigenesis of NF2-Associated Schwannomas," (The Journal of Biological Chemistry, Vol. 288, Issue 40, 29105-29114) are Silvia Licciuli and Scott Troutman of TSRI; and Jasna Maksimoska and Chu Zhou of The Wistar Institute (Philadelphia, PA). Other authors include Smitha Kota of TSRI; Qin Liu and Ronen Marmorstein of The Wistar Institute; Sergio Duron and David Campbell of Afraxis, Inc. (San Diego); Jonathan Chernoff of Fox Chase Cancer Center (Philadelphia, PA) and Jeffrey Field of University of Pennsylvania Perlman School of Medicine. For more information on the paper, see: http://www.jbc.org/content/early/2013/08/19/jbc.M113.510933.abstract
The study was supported by the National Institutes of Health (grant numbers CA124495, CA114046 and CA148805); the American Cancer Society (RSG-10-018-01-CDD) and Afraxis, Inc.
Scripps Florida scientists identify potential new drug for inherited cancer
2013-10-03
ELSE PRESS RELEASES FROM THIS DATE:
Cats adapt food selection to meet demands of lactation
2013-10-03
Portland, Ore., USA (October 3, 2013) --- Lactating cats not only increase their total calorie consumption, they also significantly alter the make-up of their diet to meet the demands of feeding a litter, research from the WALTHAM® Centre for Pet Nutrition has shown. The research provides intriguing insights into cats' feeding behaviour and strong evidence that they are able to adapt their macronutrient intake, i.e. their intake of protein, fat and carbohydrate, to meet their physiological requirements.
"It's no surprise that, just like humans, cats require more energy ...
Blocking nerve cells could prevent symptoms of eczema
2013-10-03
A new picture of how the nervous system interacts with the immune system to cause the itch and inflammation associated with eczema, a chronic skin disease, could lead to new therapies for the condition, according to University of California, Berkeley, scientists.
Some 10 percent of the population suffers from eczema, or atopic dermatitis, at some point in their lives, but there are no cures or even good treatments for it. Symptoms range from dry, flaky and itchy skin to flaming red rashes, and in severe cases, particularly in children, the disease often progresses to ...
Advanced technology for gene expression analysis can facilitate drug development
2013-10-03
When developing new drugs, monitoring cellular responses to candidate compounds is essential for assessing their efficacy and safety. Researchers from the RIKEN Center for Life Science Technologies report a new method to monitor and quantify the activity of gene promoters during the response to a drug, using the advanced gene expression analysis method CAGE followed by single-molecule sequencing. This research paves the way to a more precise analysis of cellular responses to drugs, at the level of individual promoters.
The study is published this week in the journal ...
Identifying people by their bodies when faces are no help
2013-10-03
Every day we recognize friends, family, and co-workers from afar -- even before we can distinctly see a face. New research reveals that when facial features are difficult to make out, we readily use information about someone's body to identify them -- even when we don't know we're doing so.
"Psychologists and computer scientists have concentrated almost exclusively on the role of the face in person recognition," explains lead researcher, Allyson Rice of the University of Texas at Dallas. "But our results show that the body can also provide important and useful identity ...
New advances in the study of human mitochondrial DNA
2013-10-03
A study concerning the evolution of mitochondrial DNA, performed by researchers from the Universitat Autònoma de Barcelona (UAB), has allowed to determine the frequency and pattern of heteroplasmy in the complete mitochondrial genome using a representative sample of the European population. This phenomenon, which indicates the presence of different mitochondrial DNA types in a cell or an individual, can be found in more than half of the population. The data obtained indicates that many of the newly arising mutations found never reach fixation at the population level due ...
Why do humans pig out?
2013-10-03
Researchers from University of Copenhagen have discovered big differences in the variability of eating habits among pigs. The newly published study showed that for some (pigs with certain genetic variants) overeating was normal behavior and for a particular group of pigs there was clear evidence they were genetically programmed to eat more food than others. The study was led by professor Haja Kadarmideen and is the first study in the world looking at pig to human comparative genetic mapping to reveal key genes on the human genome that are known to be involved in human obesity. ...
The order of words
2013-10-03
Think of a frequently used noun or verb in our language. Try to count how many times you have uttered it in the last two hours. Now, do the same with the article "the". The language we speak is not only made of content words (nouns, verbs, adjectives, for instance) but also of lots of words that provide a support to them (articles, prepositions, etc.) that are used much more frequently than the first (function words, or functors). Despite the huge variability of known languages, language scientists were able to divide them roughly into two main categories: the languages ...
Rare research into false killer whales reveals anti-predator partnerships
2013-10-03
False killer whales (Pseudorca crassidens) are one of the least studied species of ocean dolphin, but new light has been cast on their behavior by a team of marine scientists from New Zealand. The research, published in Marine Mammal Science, reveals how a population off the coast of New Zealand has developed a relationship with bottlenose dolphins to defend themselves from predation.
The 17-year study revealed that all 61 individuals in the area were linked in a single social network, while 88% of identified individuals were re-sighted in the same area over several ...
Great potential for faster diagnoses with new method
2013-10-03
The more accurately we can diagnose a disease, the greater the chance that the patient will survive. That is why many researchers are working to improve the quality of the diagnostic process. Researchers at the Nano-Science Center, University of Copenhagen have discovered a method that will make the process faster, cheaper and more accurate. This is possible, because they are combining advanced tools used in physics for research in biology at nanoscale, two scientific disciplines usually very distant from each other.
Many diseases can be diagnosed using so-called biomarkers. ...
5 regular meals a day reduce obesity risk among adolescents
2013-10-03
A regular eating pattern may protect adolescents from obesity, according to a Finnish population-based study with more than 4,000 participants. When eating five meals – breakfast, lunch, dinner and two snacks – a day, even those with a genetic predisposition to obesity had no higher body mass index (BMI) than their controls.
The collection of the data on the study population began prenatally, and the participants were followed up until the age of 16. The aim was to identify early-life risk factors associated with obesity, to investigate the association between meal frequencies, ...